Original article| Volume 54, ISSUE 12, P1330-1337, December 15, 2003

Enduring behavioral effects of early exposure to methylphenidate in rats



      Methylphenidate (MPH) is a stimulant prescribed for the treatment of attention-deficit/hyperactivity disorder (ADHD). Stimulant drugs can cause enduring behavioral adaptations, including altered drug sensitivity, in laboratory animals. We examined how early developmental exposure to stimulants affects behavior in several rodent models.


      Rats received MPH or cocaine during preadolescence (P20–35). Behavioral studies began during adulthood (P60). We compared how early exposure to MPH and cocaine affects sensitivity to the rewarding and aversive properties of cocaine using place conditioning. We also examined the effects of early exposure to MPH on depressive-like signs using the forced swim test, and habituation of spontaneous locomotion, within activity chambers.


      In place-conditioning tests, early exposure to MPH or cocaine each made moderate doses of cocaine aversive and high doses less rewarding. Early MPH exposure also caused depressive-like effects in the forced swim test, and it attenuated habituation to the activity chambers.


      Early exposure to MPH causes behavioral changes in rats that endure into adulthood. Some changes (reduced sensitivity to cocaine reward) may be beneficial, whereas others (increases in depressive-like signs, reduced habituation) may be detrimental. The effects of MPH on cocaine-related behaviors may be a general consequence of early stimulant exposure.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Andersen S.L.
        • Arvanitogiannis A.
        • Pliakas A.M.
        • LeBlanc C.
        • Carlezon Jr., W.A.
        Altered responsiveness to cocaine in rats exposed to methylphenidate during development.
        Nature Neurosci. 2002; 5: 13-14
        • Andersen S.L.
        • Thompson A.P.
        • Krenzel E.
        • Teicher M.H.
        Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction.
        Psychoneuroendocrinology. 2002; 27: 683-691
        • Biederman J.
        • Wilens T.
        • Mick E.
        • Spencer T.
        • Faraone S.V.
        Pharmacotherapy of attention deficit/hyperactivity disorder reduces risk for substance use disorder.
        Pediatrics. 1999; 104: e20
      1. Bolaños CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003): Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54:1317–1329

        • Brandon C.L.
        • Marinelli M.
        • Baker L.K.
        • White F.J.
        Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats.
        Neuropsychopharmacol. 2001; 25: 651-661
        • Busidan Y.
        • Dow-Edwards D.L.
        Behavioral sensitization to apomorphine in adult rats exposed to cocaine during the preweaning period.
        Pharmacol Biochem Behav. 1999; 63: 417-421
        • Carlezon Jr, W.A.
        • Boundy V.A.
        • Haile C.N.
        • Lane S.B.
        • Kalb R.G.
        • Neve R.L.
        • Nestler E.J.
        Sensitization to morphine induced by viral-mediated gene transfer.
        Science. 1997; 277: 812-814
        • Carlezon Jr, W.A.
        • Nestler E.J.
        Elevated levels of GluR1 in the midbrain.
        Trends Neurosci. 2002; 25: 610-615
        • Carlezon Jr, W.A.
        • Pliakas A.M.
        • Parow A.M.
        • Detke M.J.
        • Cohen B.M.
        • Renshaw P.F.
        Antidepressant-like effects of cytidine in the forced swim test in rats.
        Biol Psychiatry. 2002; 51: 882-889
        • Carlezon Jr, W.A.
        • Thome J.
        • Olson V.
        • Lane-Ladd S.B.
        • Brodkin E.S.
        • Hiroi N.
        • et al.
        Regulation of cocaine reward by CREB.
        Science. 1998; 282: 2272-2275
        • Carr G.D.
        • Fibiger J.C.
        • Phillips A.G.
        Conditioned place preference as a measure of drug reward.
        in: Liebman J.M. Cooper S.J. The Neuropharmacological Basis of Reward. Clarendon, Oxford1989: 264-319
        • Detke M.J.
        • Rickels M.
        • Lucki I.
        Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants.
        Psychopharmacol. 1995; 121: 66-72
        • Di Chiara G.
        • Imperato A.
        Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
        Proc Natl Acad Sci U S A. 1988; 85: 5274-5278
        • Horger B.A.
        • Giles M.K.
        • Schenk S.
        Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine.
        Psychopharmacol. 1992; 107: 271-276
        • Horger B.A.
        • Shelton K.
        • Schenk S.
        Preexposure sensitizes rats to the rewarding effects of cocaine.
        Pharmacol Biochem Behav. 1990; 37: 707-711
        • Kalivas P.W.
        • Stewart J.
        Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.
        Brain Res Brain Res Rev. 1991; 16: 223-244
        • Koob G.F.
        • Le Moal M.
        Drug addiction, dysregulation of reward, and allostasis.
        Neuropsychopharmacol. 2001; 24: 97-129
        • Kuczenski R.
        • Segal D.S.
        Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine.
        J Neurochem. 1997; 68: 2032-2037
        • Kuczenski R.
        • Segal D.S.
        Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate.
        J Pharmacol Exper Ther. 2001; 296: 876-883
        • Kuczenski R.
        • Segal D.S.
        Exposure of adolescent rats to oral methylphenidate.
        J Neurosci. 2002; 22: 7264-7271
        • Lett B.T.
        Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine.
        Psychopharmacol. 1989; 98: 357-362
      2. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, et al (2003): Antidepressant-like effects of kappa opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323–330

        • Morris R.G.
        • Garrud P.
        • Rawlins J.N.
        • O'Keefe J.
        Place navigation impaired in rats with hippocampal lesions.
        Nature. 1982; 297: 681-683
        • Nestler E.J.
        Molecular basis of long-term plasticity underlying addiction.
        Nat Rev Neurosci. 2001; 2: 119-128
        • Overstreet D.H.
        • Pucilowski O.
        • Rezvani A.H.
        • Janowsky D.S.
        Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression.
        Psychopharmacol. 1995; 121: 27-37
        • Piazza P.V.
        • Deminiere J.M.
        • Le Moal M.
        • Simon H.
        Factors that predict individual vulnerability to amphetamine self-administration.
        Science. 1989; 245: 1511-1513
        • Pliakas A.M.
        • Carlson R.
        • Neve R.L.
        • Konradi C.
        • Nestler E.J.
        • Carlezon Jr., W.A.
        Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element binding protein expression in nucleus accumbens.
        J Neurosci. 2001; 21: 7397-7403
        • Pontieri F.E.
        • Tanda G.
        • Orzi F.
        • Di Chiara G.
        Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
        Nature. 1996; 382: 255-257
        • Porsolt R.D.
        • Le Pichon M.
        • Jalfre M.
        Nature. 1977; 266: 730-732
        • Post R.M.
        • Rose H.
        Increasing effects of repetitive cocaine administration in the rat.
        Nature. 1976; 260: 731-732
        • Ritz M.C.
        • Kuhar M.J.
        Relationship between self-administration of amphetamine and monoamine receptors in brain.
        J Pharmacol Exp Ther. 1989; 248: 1010-1017
        • Robbins T.W.
        The 5-choice serial reaction time task.
        Psychopharmacol. 2002; 163: 362-380
        • Robinson T.E.
        • Becker J.B.
        Enduring changes in brain and behavior produced by chronic amphetamine administration.
        Brain Res. 1986; 396: 157-198
        • Robinson T.E.
        • Berridge K.C.
        The psychology and neurobiology of addiction.
        Addiction. 2000; 95: S91-S117
        • Segal D.S.
        • Mandell A.J.
        Long-term administration of d-amphetamine.
        Pharmacol Biochem Behav. 1974; 2: 249-255
        • Solomon R.L.
        • Corbit J.D.
        An opponent-process theory of motivation. I. Temporal dynamics of affect.
        Psychol Rev. 1974; 81: 119-145
        • Spencer T.
        • Biederman J.
        • Wilens T.
        • Harding M.
        • O'Donnell D.
        • Griffin S.
        Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.
        J Am Acad Child Adolesc Psychiatry. 1996; 35: 343-351
        • Strakowski S.M.
        • Sax K.W.
        Progressive behavioral response to repeated D-amphetamine challenge.
        Biol Psychiatry. 1998; 44: 1171-1177
        • Swanson J.M.
        • Seargeant J.A.
        • Taylor E.
        • Sonuga-Barke E.J.S.
        • Jensen P.S.
        • Cantwell D.P.
        Attention deficit disorder and hyperkinetic disorder.
        Lancet. 1998; 351: 429-433
        • Taylor F.B.
        • Russo J.
        Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder.
        J Clin Psychopharmacol. 2001; 21: 223-228
        • Teicher M.H.
        • Andersen S.L.
        • Wallace P.
        • Klein D.A.
        • Hostetter J.
        Development of an affordable hi-resolution activity monitor system for laboratory animals.
        Pharmacol Biochem Behav. 1996; 54: 479-483
        • Teicher M.H.
        • Ito Y.
        • Glod C.A.
        • Barber N.I.
        Objective measurement of hyperactivity and attentional problems in ADHD.
        J Am Acad Child Adolesc Psychiatry. 1996; 35: 334-342
        • Vanderschuren L.J.M.J.
        • Kalivas P.W.
        Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization.
        Psychopharmacol. 2000; 151: 99-120
        • Volkow N.D.
        • Wang G.
        • Fowler J.S.
        • Logan J.
        • Gerasimov M.
        • Maynard L.
        • et al.
        Therapeutic doses of oral methylphenidate significantly increases extracellular dopamine in the human brain.
        J Neurosci. 2001; 21: RC121
        • Wargin W.
        • Kilts P.C.
        • Gualtieri C.T.
        • Ellington K.R.
        • Mueller R.A.
        • Kraemer G.
        • Breese G.R.
        Pharmacokinetics of methylphenidate in man, rat and monkey.
        J Pharmacol Exp Ther. 1983; 226: 382-386
        • Wilens T.E.
        • Faraone S.V.
        • Biederman J.
        • Gunawardene S.
        Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
        Pediatrics. 2003; 111: 179-185
        • Willner P.
        The validity of animal models of depression.
        Psychopharmacol. 1984; 83: 1-16
        • Wise R.A.
        • Bozarth M.A.
        A psychomotor stimulant theory of addiction.
        Psychol Rev. 1987; 94: 469-492
        • Zito J.M.
        • Safer D.J.
        • dosReis S.
        • Gardner J.F.
        • Boles M.
        • Lynch F.
        Trends in the prescribing of psychotropic medications to preschoolers.
        JAMA. 2000; 283: 1025-1030